AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 14 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 5.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $36,674,000 | +2.6% | 52,392,000 | 0.0% | 0.37% | -6.6% |
| Q1 2019 | $35,758,000 | -18.6% | 52,392,000 | 0.0% | 0.39% | -24.9% |
| Q4 2018 | $43,937,000 | +11.1% | 52,392,000 | 0.0% | 0.52% | +16.3% |
| Q3 2018 | $39,556,000 | +16.2% | 52,392,000 | 0.0% | 0.45% | +5.9% |
| Q2 2018 | $34,055,000 | -15.6% | 52,392,000 | 0.0% | 0.42% | -26.1% |
| Q1 2018 | $40,342,000 | -3.4% | 52,392,000 | +1.5% | 0.57% | -3.9% |
| Q4 2017 | $41,765,000 | +0.1% | 51,642,000 | 0.0% | 0.60% | -4.3% |
| Q3 2017 | $41,704,000 | -99.9% | 51,642,000 | +21.1% | 0.62% | +12.4% |
| Q2 2017 | $35,019,742,000 | +128412.8% | 42,642,000 | +26.8% | 0.56% | +20.7% |
| Q1 2017 | $27,250,000 | – | 33,642,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 1,500,000 | $1,219,000 | 0.82% |
| EdgePoint Investment Group Inc. | 51,642,000 | $41,704,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,600,000 | $13,359,000 | 0.60% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 43,150,000 | $34,952,000 | 0.52% |
| Tekla Capital Management LLC | 13,000,000 | $10,303,000 | 0.37% |
| UBS OCONNOR LLC | 26,000,000 | $20,669,000,000 | 0.30% |
| Orbimed Advisors | 15,000,000 | $12,151,000 | 0.12% |
| Baker Brothers Advisors | 9,517,000 | $7,576,000 | 0.06% |
| CSS LLC/IL | 653,000 | $517,000 | 0.02% |
| Allianz Asset Management GmbH | 28,680,000 | $23,232,000 | 0.02% |